Scopio Labs has received a de novo clearance from the FDA for its artificial-intelligence-powered system that analyzes bone marrow biopsies to help diagnose a range of blood disorders, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback